1995
DOI: 10.1016/0142-9612(95)91046-2
|View full text |Cite
|
Sign up to set email alerts
|

Azo polymeric hydrogels for colon targeted drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
34
0

Year Published

1999
1999
2010
2010

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 76 publications
(36 citation statements)
references
References 11 publications
0
34
0
Order By: Relevance
“…The azo dye Direct Black 38 is metabolized to the mutagen benzidine by human intestinal bacteria [48]. The ability of the bacteria residing in the human intestinal tract to reduce azo dyes has led to the development of drugs that are azo-linked to nontherapeutic moieties and polymeric azo prodrugs that provide colon-specific delivery of active metabolites [49][50][51][52]. After ingestion, the azoreductases from colonic bacteria cleave the azo bonds, releasing the drugs in their active forms [47,52,53].…”
Section: Bacteriamentioning
confidence: 99%
“…The azo dye Direct Black 38 is metabolized to the mutagen benzidine by human intestinal bacteria [48]. The ability of the bacteria residing in the human intestinal tract to reduce azo dyes has led to the development of drugs that are azo-linked to nontherapeutic moieties and polymeric azo prodrugs that provide colon-specific delivery of active metabolites [49][50][51][52]. After ingestion, the azoreductases from colonic bacteria cleave the azo bonds, releasing the drugs in their active forms [47,52,53].…”
Section: Bacteriamentioning
confidence: 99%
“…The designing of prodrugs is based on the concept of preventing the release of drugs in the stomach and small intestine, and drug release is triggered by the utilization of some specific property at the target site such as altered pH or high activity of certain enzymes in comparison to nontarget tissues (Davaran et al 1999;Schacht et al 1996). Since it is known that azo function can be reduced in the colon (Chung et al 1992), a lot of novel polymers containing azo groups either in the polymeric backbone (Yamaoka et al 2000) or in the crosslinks (Shantha et al 1995; Van den Mooter et al 1992) have been synthesized. In order to promote further selective degradation in the vicinity of colonic environment, delivery systems have been designed that contain both pH-sensitive acidic monomers and degradable azo aromatic crosslinks (Chandehari et al 1997;Kakoulides et al 1998).…”
Section: Introductionmentioning
confidence: 99%
“…Several attempts have been made to increase effective concentration and reduce toxicity via oral colon-specific delivery systems (Huang et al, 2001;Shantha et al, 1995). Precise colonic drug delivery requires that the triggering mechanism in the delivery system only responds to the physiological conditions particular to the colon.…”
Section: Introductionmentioning
confidence: 99%